April 27, 2023 at 12:03AM FDA Approves First Orally Administered Fecal Microbiota Product for the Prevention of Recurrence of Clostridioides difficile Infection

FDA approves Vowst, the first orally administered fecal microbiota product. Vowst is approved for the prevention of recurrence of Clostridioides difficile infection in individuals 18 years of age and older, following completion of antibacterial treatment for recurrent CDI.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Eyvan9Z